
The current CVS market cap is 82.78B. The company's latest EPS is USD 3.6596 and P/E is 17.95.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 93.81B | 88.44B | 91.23B | 95.43B | 97.71B |
Operating Income | 3.37B | 2.27B | 3.05B | 832M | 2.37B |
Net Income | 2.05B | 1.11B | 1.77B | 87M | 1.64B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 268.71B | 292.11B | 322.47B | 357.78B | 372.81B |
Operating Income | 13.91B | 14.55B | 10.28B | 14.09B | 8.52B |
Net Income | 7.19B | 7.91B | 4.15B | 8.34B | 4.61B |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 249.73B | 249.74B | 252.48B | 252.43B | 253.22B |
Total Liabilities | 173.09B | 175.59B | 177.37B | 177.32B | 177.49B |
Total Equity | 76.64B | 74.15B | 75.11B | 75.11B | 75.73B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 230.72B | 233B | 228.28B | 249.73B | 253.22B |
Total Liabilities | 161.01B | 157.62B | 156.96B | 173.09B | 177.49B |
Total Equity | 69.7B | 75.38B | 71.32B | 76.64B | 75.73B |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 13.43B | 4.9B | 7.99B | 7.25B | 9.11B |
Investing | -20.89B | -2.09B | -3.72B | -7.07B | -7.61B |
Financing | 2.68B | -1.23B | 22M | -1.57B | -1.14B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 15.87B | 18.27B | 16.18B | 13.43B | 9.11B |
Investing | -5.53B | -5.26B | -5.05B | -20.89B | -7.61B |
Financing | -8.16B | -11.36B | -10.52B | 2.68B | -1.14B |
Market Cap | 82.78B |
Price to Earnings Ratio | 17.95 |
Price to Sales Ratio | 0.22 |
Price to Cash Ratio | 9.64 |
Price to Book Ratio | 1.09 |
Dividend Yield | 4.05% |
Shares Outstanding | 1.26B |
Average Volume (1 week) | 8.82M |
Average Volume (1 Month) | 8.82M |
52 Week Change | -12.18% |
52 Week High | 80.75 |
52 Week Low | 43.56 |
Spread (Intraday) | 0.15 (0.23%) |
Company Name | CVS Health Corporation |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.cvshealth.com |
Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.